Manchester Science Partnerships (MSP) is targeting global life science companies in the US. A team from MSP led by Managing Director Tom Renn will be visiting Philadelphia and Boston to meet key contacts and prospects following the major announcement earlier this year that a world-leading precision medicine hub will be created in Manchester at its Citylabs campus.

After visiting the global MedTech Conference in Philadelphia, the MSP team will join up with MIDAS – Manchester’s inward investment agency for a series of high level, one-on-one meetings and roadshows in Boston.

Read the full article

Submitted on 25/09/2018